
Sign up to save your podcasts
Or
What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/
5
3939 ratings
What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/
410 Listeners
399 Listeners
610 Listeners
587 Listeners
415 Listeners
484 Listeners
520 Listeners
246 Listeners
4,858 Listeners
3,520 Listeners
9,354 Listeners
7,947 Listeners
717 Listeners
180 Listeners
1,133 Listeners